Race Oncology Limited (RAONF)
USD 1.22
(0.0%)
USD 1.22
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 | -0.08 AUD | -36.14% |
| 2023 | -0.06 AUD | 18.45% |
| 2022 | -0.05 AUD | -38.84% |
| 2021 | -0.04 AUD | -46.37% |
| 2020 | -0.02 AUD | 22.98% |
| 2019 | -0.03 AUD | 53.4% |
| 2018 | -0.07 AUD | -13.84% |
| 2017 | -0.06 AUD | -1248.89% |
| 2016 | -0.00 AUD | 92.69% |
| 2015 | -0.06 AUD | -679.75% |
| 2014 | -0.01 AUD | -777.78% |
| 2013 | -0.00 AUD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q4 | -0.03 USD | 0.0% |
| 2024 Q2 | -0.02 USD | 0.0% |
| 2023 Q4 | -0.02 USD | 0.0% |
| 2023 FY | - AUD | 18.45% |
| 2023 Q2 | -0.02 USD | 0.0% |
| 2022 Q2 | -0.02 USD | 0.0% |
| 2022 FY | - AUD | -38.84% |
| 2022 Q4 | -0.03 USD | 0.0% |
| 2021 Q4 | -0.02 USD | 0.0% |
| 2021 FY | - AUD | -46.37% |
| 2021 Q2 | -0.01 USD | 0.0% |
| 2020 Q4 | -0.01 USD | 0.0% |
| 2020 Q2 | -0.01 USD | 0.0% |
| 2020 FY | - AUD | 22.98% |
| 2019 FY | - AUD | 53.4% |
| 2019 Q4 | -0.01 USD | 0.0% |
| 2018 FY | - AUD | -13.84% |
| 2017 FY | - AUD | -1248.89% |
| 2016 FY | - AUD | 92.69% |
| 2015 FY | - AUD | -679.75% |
| 2014 FY | - AUD | -777.78% |
| 2013 FY | - AUD | 0.0% |